Le Lézard
Classified in: Health
Subject: AVO

Heart & Stroke applauds federal government's introduction of pharmacare legislation, looks forward to expanding plan in future to include essential drugs


Today's announcement the first step toward equal access to lifesaving drugs    

OTTAWA, ON, Feb. 29, 2024 /CNW/ - Heart & Stroke congratulates the federal government for introducing pharmacare legislation today, lauding the affordable plan that will give 7.5 million uninsured and underinsured people in Canada access to prescription drugs for diabetes and contraception. We also acknowledge the important role the NDP has been playing on this issue.  

"We're thrilled to see the federal government take this historic action by tabling a national pharmacare program," says Doug Roth, Heart & Stroke CEO. "People with diabetes are three times more likely to die from heart disease and it affects the most vulnerable members of our society. This is a terrific first step."  

Heart & Stroke is asking the federal government to work quickly to expand the program in a fiscally prudent way by adding to it a list of essential medicines, including prescription drugs for heart conditions and stroke, as recommended in the government's 2019 Hoskins Report on pharmacare. More than 600 people in Canada die every year from ischemic heart disease because they can't afford their medication.   

"Today's announcement is only the beginning," Roth says. "We know that 16% of people in Canada living with heart conditions have trouble affording their blood pressure, cholesterol and heart disease prescriptions. The next step is for the federal government to ensure access to these essential prescription drugs for all people living in Canada."

About Heart & Stroke
Life. We don't want you to miss it. That's why Heart & Stroke has been leading the fight to beat heart disease and stroke for more than 70 years. We must generate the next medical breakthroughs, so Canadians don't miss out on precious moments. Together, with the generous support of our donors, partners, and volunteers, we are working to prevent disease, save lives and promote recovery through research, health promotion and public policy.?Heartandstroke.ca @heartandstroke 

SOURCE Heart and Stroke Foundation


These press releases may also interest you

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced that it is scheduled to participate in the following upcoming events: 2024 RBC Capital Markets Global Healthcare Conference ? May 14-15, 2024 Type: Fireside Chat Presentation Date/Time: May 14,...

at 07:25
Prota Therapeutics' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards. Professor Tang's exceptional work as a lead researcher for the Murdoch Children's Research Institute (MCRI) and her...

at 07:15
International medical imaging IT and Cybersecurity company Sectra's (STO: SECT B) digital pathology solution together with Leica Biosystems, Imaging, Inc.'s Aperio GT 450 DX have received a 510(k) clearance by the US Food & Drug Administration (FDA)....

at 07:11
Author C.A. Blake was 24 years old when her brother, Steve, committed suicide. She struggled with the feeling she wouldn't survive the pain of it. Growing up in a time where little to no coping skills were taught or offered, she traveled the path of...

at 07:05
Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective...



News published on and distributed by: